Thymosin Alpha-1 High-Purity Immune Modulating Peptide for Advanced Research CAS 62304-98-7 Use

Name：Lucy

Whatsapp:+86 19912017313

Email:m19912017313@163.com

Thymosin alpha 1 α 1 ) is a peptide that treats chronic hepatitis B and enhances immune system responsiveness. thymus increases the secretion of interfer by T cells after antigen or mitogen activation α, interfer γ And the levels of lymphokines such as interleukin-2 and interleukin-3, while increasing the level of lymphokine receptors on the surface of T cells. It is also possible to enhance the mixed lymphocyte response of allogeneic and autologous humans by activating CD4 cells. Thymic peptide α 1 may increase the aggregation of pre NK cells, while interfer can enhance their cytotoxicity. In vivo experiments have shown that thymosin alpha1 can increase the expression level of interleukin-2 receptors in mouse lymphocytes activated by concanavalin A, while also increasing the secretion level of interleukin-2. Current thymic peptides on the market α The synthesis preparation method has a long synthesis cycle and high production cost, which is not conducive to the large-scale production of bivaludine.

 We are a chemical manufacturer integrating production, processing and export, mainly dealing in pharmaceutical intermediates and various industrial chemicals. Since its establishment, the company adheres to the spirit of "integrity management, strict quality control, customer first", and has won praise from customers at home and abroad.  We have also established an excellent professional sales team with rich international marketing experience, able to efficiently provide a range of products and professional services.

    With synthetic biology platform technology as the core, it conducts innovative research and development, mainly engaged in the research and development of recombinantly expressed pharmaceutical peptides and proteins. Its products include innovative drugs, APIs, pharmaceutical and green synthetic industrial enzymes, functional peptides and protein products, etc.

    At present, our company has realized the industrialization of a variety of biosynthetic peptide products and has obtained cooperation orders from many well-known domestic and foreign pharmaceutical companies.